Park Square is pleased to announce the placement of Thomas Strack, M.D., as Chief Medical Officer at Faeth Therapeutics. Faeth is a data-driven, evidence-based company developing a deep mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatments. Faeth focuses on matching specific diets with different tumor genotypes and treatments to improve cancer therapy outcomes.